VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
IDYA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
IDYAIDEAYA Biosciences, Inc.
$31.24$2.7B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksIDYAQuarterly Financials

IDEAYA Biosciences, Inc. (IDYA) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

IDEAYA Biosciences, Inc. (IDYA) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

IDYA Income Statement

Quarterly statement

IDYA Income Statement

IDEAYA Biosciences, Inc. (IDYA) annual income statement — 9-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Sales/Revenue10.24M8.86M6.56M10.88M207.83M007M0003.92M8.04M3.54M7.88M4.02M29.7M5.85M11.36M2.96M
Revenue Growth %-95.07%--55.37%---78.43%-100%-100%-100%-2.46%-72.94%-39.43%-30.63%35.74%230.87%-33.18%56.74%-71.97%
Cost of Goods Sold00000000001.08M1.02M986K998K960K558K925K1.2M464K425K
COGS % of Revenue-----------26.1%12.27%28.16%12.18%13.87%3.11%20.58%4.08%14.34%
Gross Profit10.24M8.86M6.56M10.88M207.83M007M00-1.08M2.9M7.05M2.55M6.92M3.46M28.77M4.65M10.89M2.54M
Gross Margin %100%100%100%100%100%--100%---73.9%87.73%71.84%87.82%86.13%96.89%79.42%95.92%85.66%
Gross Profit Growth %-95.07%--55.37%--100%141.46%-100%-100%-115.64%-16.31%-75.49%-45.21%-36.48%36.49%540.85%174.67%352.26%-75.14%
Operating Expenses147.87M131.15M115.1M105.45M99.38M88.81M84.39M151.14M66.89M64.93M49.94M44.81M40.58M35.26M33.2M29.91M28.11M27.15M25.11M20.91M
OpEx % of Revenue1443.8%1480.73%1754.63%969.53%47.82%--2159.11%---1142.34%504.83%994.78%421.31%743.59%94.66%463.95%221.1%705.6%
Selling, General & Admin26.3M22.46M19.38M18.85M16.39M14.58M13.5M10.96M9.74M10.39M7.13M6.04M6.88M6.08M5.34M5.19M5.74M4.35M5.46M4.8M
SG&A % of Revenue256.77%253.57%295.4%173.29%7.89%--156.5%---154.07%85.56%171.47%67.77%129.14%19.33%74.35%48.06%161.93%
Research & Development121.58M108.69M95.73M86.6M82.99M74.23M70.89M140.18M57.15M54.53M42.8M38.77M33.7M29.18M27.86M24.71M22.37M22.8M19.66M16.11M
R&D % of Revenue1187.03%1227.15%1459.24%796.24%39.93%--2002.61%---988.27%419.27%823.31%353.54%614.47%75.33%389.61%173.04%543.67%
Other Operating Expenses000000000000000-1K0000
Operating Income-137.63M-122.29M-108.54M-94.57M108.45M-88.81M-84.39M-144.14M-66.89M-64.93M-51.02M-41.92M-33.53M-32.71M-26.28M-26.44M660K-22.5M-14.22M-18.37M
Operating Margin %-1343.8%-1380.73%-1654.63%-869.53%52.18%---2059.11%----1068.49%-417.09%-922.94%-333.49%-657.48%2.22%-384.53%-125.19%-619.95%
Operating Income Growth %-226.91%-37.71%-28.62%34.39%262.13%-36.78%-65.41%-243.87%-99.53%-98.5%-94.14%-58.51%-5179.7%-45.38%-84.8%-43.96%105.63%-103.59%-55.66%-247.9%
EBITDA-137.02M-121.17M-107.86M-93.85M109.11M-88.09M-83.79M-143.57M-66.32M-64.31M-49.94M-40.89M-32.54M-31.71M-25.32M-25.89M1.58M-21.3M-13.76M-17.94M
EBITDA Margin %-1337.81%-1368.07%-1644.15%-862.9%52.5%---2050.94%----1042.39%-404.83%-894.78%-321.31%-643.61%5.34%-363.95%-121.1%-605.6%
EBITDA Growth %-225.57%-37.56%-28.72%34.63%264.54%-36.98%-67.8%-251.08%-103.8%-102.78%-97.22%-57.97%-2153%-48.91%-84.06%-44.26%114.14%-99.93%-57.16%-264.79%
D&A (Non-Cash Add-back)614K1.12M688K721K661K718K600K572K577K622K1.08M1.02M986K998K960K558K925K1.2M464K425K
EBIT-137.63M-122.29M-98.54M-83.27M119.24M-77.49M-72.18M-130.31M-51.82M-52.77M-39.57M-33.95M-27.44M-27.93M-23.64M-24.2M1.61M-22.06M-14.01M-18.21M
Net Interest Income11.88M9.84M10.01M11.3M10.79M11.31M12.21M13.83M15.07M12.15M11.45M7.96M6.09M4.78M2.64M2.24M955K443K207K157K
Interest Income11.88M9.84M10.01M11.3M10.79M11.31M12.21M13.83M15.07M12.15M11.45M7.96M6.09M4.78M2.64M2.24M955K443K207K157K
Interest Expense00000000000000000000
Other Income/Expense11.88M9.84M10.01M11.3M10.79M11.31M12.21M13.83M15.07M12.15M11.45M7.96M6.09M4.78M2.64M2.24M955K443K207K157K
Pretax Income-125.75M-112.45M-98.54M-83.27M119.24M-77.49M-72.18M-130.31M-51.82M-52.77M-39.57M-33.95M-27.44M-27.93M-23.64M-24.2M1.61M-22.06M-14.01M-18.21M
Pretax Margin %-1227.78%-1269.64%-1502.12%-765.66%57.37%---1861.6%----865.54%-341.38%-787.98%-300%-601.72%5.44%-376.96%-123.36%-614.65%
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-125.75M-112.45M-98.54M-83.27M119.24M-77.49M-72.18M-130.31M-51.82M-52.77M-39.57M-33.95M-27.44M-27.93M-23.64M-24.2M1.61M-22.06M-14.01M-18.21M
Net Margin %-1227.78%-1269.64%-1502.12%-765.66%57.37%---1861.6%----865.54%-341.38%-787.98%-300%-601.72%5.44%-376.96%-123.36%-614.65%
Net Income Growth %-205.46%-45.12%-36.52%36.1%330.11%-46.84%-82.4%-283.78%-88.85%-88.97%-67.39%-40.3%-1799.07%-26.61%-68.7%-32.88%113.94%-101.48%-55.34%-254.66%
Net Income (Continuing)-125.75M-112.45M-98.54M-83.27M119.24M-77.49M-72.18M-130.31M-51.82M-52.77M-39.57M-33.95M-27.44M-27.93M-23.64M-24.2M1.61M-22.06M-14.01M-18.21M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-1.22-1.22-1.11-0.941.33-0.88-0.82-1.49-0.60-0.68-0.53-0.52-0.46-0.50-0.41-0.460.06-0.56-0.47-0.47
EPS Growth %-191.73%-38.64%-35.37%36.91%321.67%-29.41%-54.72%-186.54%-30.43%-36%-29.27%-13.04%-836%10.71%12.77%2.13%120.16%-69.7%-67.86%-161.11%
EPS (Basic)-1.22-1.22-1.11-0.941.35-0.88-0.82-1.49-0.60-0.68-0.53-0.52-0.46-0.50-0.41-0.460.06-0.56-0.47-0.47
Diluted Shares Outstanding102.94M92.06M88.7M88.58M89.69M88.47M88.36M81.68M86.19M77.96M75.11M65.25M60M56.25M48.37M48.13M41.11M38.66M38.59M38.5M
Basic Shares Outstanding102.94M92.06M88.7M88.58M88.53M88.47M88.36M81.68M86.19M77.96M75.11M65.25M60M56.25M48.37M48.13M40.3M38.66M38.59M38.36M
Dividend Payout Ratio--------------------